other material
confidence low
sentiment neutral
materiality 0.20
ORIC updates ORIC-944 dose exploration data in corporate presentation
Oric Pharmaceuticals, Inc.
- ORIC furnished updated ORIC-944 data slides for investor presentations (Exhibit 99.1).
- No specific numerical data or endpoints from the slides were disclosed in the filing.
- The presentation is for future use and does not contain financial results or guidance.